This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hu, L. Articles by Klein, G. Search for Related Content PubMed PubMed Citation Articles by Hu, L. Articles by Klein, G.

Differences in the Immunogenicity of Latent Membrane Protein 1 (LMP1) Encoded by Epstein-Barr Virus Genomes Derived from LMP1-positive and -negative Nasopharyngeal Carcinoma¹

Microbiology and Tumour Biology Centre, Karolinska Institute, S-17177 Stockholm, Sweden [L. H., B. T., X. Z., I. E., G. K.], and INM, Neuromed, 86077 Pozzilli, Italy [P. T.]

We have previously shown that an EBV-encoded latent membrane protein 1 (LMP1) gene derived from a nude mouse-propagated nasopharyngeal carcinoma (NPC) tumor and expressed in nonimmunogenic murine mammary carcinoma S6C cells failed to convey immunogenicity (rejectability) in syngeneic mice, whereas the corresponding B-cell derived LMP1 gene made the mice highly immunogenic. This raised the question of whether LMP1-expressing NPCs have been selected for low immunogenicity at the viral gene expression level. If so, LMP1-negative tumors that carry highly methylated LMP1 regulatory sequences may not have been exposed to a similar immunoselection. In the present study, we have compared LMP1 genes derived from two LMP1-positive NPCs and two LMP1-negative NPCs. All four genes were expressed in S6C cells in parallel with the previously tested isolates from a B-cell (B95-8)-derived and a nude mouse-propagated NPC (Cao)-derived gene. As in the previous study, we have found that the B-cell-derived LMP1 isolate was highly immunogenic. LMP1-positive tumor-derived isolates were poorly immunogenic, whereas the isolates from the LMP1-negative NPC tumor had intermediate immunogenicity. Sequence data revealed that LMP1 genes from LMP1-expressing NPC had 16 amino acid substitutions, whereas LMP1 from non-LMP1-expressing NPC had only 9 amino acid changes in the coding region. Three of the changes were at shared sites, but with different modifications. The fact that the gene from non-LMP1-expressing NPC mutated at a low frequency but was more immunogenic than the LMP1 gene derived from LMP1-expressing NPC, which was highly mutated but less immunogenic, favors the idea that LMP1-positive tumors escape immunosurveillance in immunocompetent hosts by either a selective down-regulation of LMP1 expression, methylation in the LMP1 promoter sequence, or mutation of LMP1 in LMP1-expressing samples.

This article has been cited by other articles:

				K.-P. N Chow, C C Wu, H Y Chang, C Chang, and Y S Chang A simplified tumour model established via Epstein-Barr virus-encoded, nasopharyngeal carcinoma-derived oncogene latent membrane protein 1 in immunocompetent mice Lab Anim, April 1, 2008; 42(2): 193 - 203. [Abstract] [Full Text] [PDF]

				D. Stevenson, C. Charalambous, and J. B. Wilson Epstein-Barr Virus Latent Membrane Protein 1 (CAO) Up-regulates VEGF and TGF{alpha} Concomitant with Hyperlasia, with Subsequent Up-regulation of p16 and MMP9 Cancer Res., October 1, 2005; 65(19): 8826 - 8835. [Abstract] [Full Text] [PDF]

				J. M. Burrows, L. Bromham, M. Woolfit, G. Piganeau, J. Tellam, G. Connolly, N. Webb, L. Poulsen, L. Cooper, S. R. Burrows, et al. Selection Pressure-Driven Evolution of the Epstein-Barr Virus-Encoded Oncogene LMP1 in Virus Isolates from Southeast Asia J. Virol., July 1, 2004; 78(13): 7131 - 7137. [Abstract] [Full Text] [PDF]

				Y. Isobe, K. Sugimoto, L. Yang, K. Tamayose, M. Egashira, T. Kaneko, K. Takada, and K. Oshimi Epstein-Barr Virus Infection of Human Natural Killer Cell Lines and Peripheral Blood Natural Killer Cells Cancer Res., March 15, 2004; 64(6): 2167 - 2174. [Abstract] [Full Text] [PDF]

				K. D. Erickson, C. Berger, W. F. Coffin III, E. Schiff, D. M. Walling, and J. M. Martin Unexpected Absence of the Epstein-Barr Virus (EBV) lyLMP-1 Open Reading Frame in Tumor Virus Isolates: Lack of Correlation between Met129 Status and EBV Strain Identity J. Virol., April 1, 2003; 77(7): 4415 - 4422. [Abstract] [Full Text] [PDF]

				C. A. Fielding, K. Sandvej, A. Mehl, P. Brennan, M. Jones, and M. Rowe Epstein-Barr Virus LMP-1 Natural Sequence Variants Differ in Their Potential To Activate Cellular Signaling Pathways J. Virol., October 1, 2001; 75(19): 9129 - 9141. [Abstract] [Full Text] [PDF]